BPC-157 vs TB-500: Differences, Uses and Prices

BPC-157 and TB-500 are two different peptides. BPC-157 is a 15-amino-acid peptide based on a protein in stomach juice, studied for tendons, ligaments and the gut lining. TB-500 is a 7-amino-acid fragment of thymosin beta-4, studied for tissue repair and muscle recovery. Both may support healing, mostly in animal research, and neither is FDA-approved.

At Padgett Medical Center in Tampa, BPC-157 costs $12 per capsule or $275 (injection, 1 vial, a month's supply), and TB-500 costs $300 (injection, 15 mg in a 4 mL vial, 1 vial). The consultation with a licensed provider is free, and new patients who book online with a card on file get 10% off their first peptide order.

What is the difference between BPC-157 and TB-500?

They come from different proteins and are different sizes. BPC-157, short for Body Protection Compound-157, is a lab-made chain of 15 amino acids whose sequence comes from a larger protein first found in human stomach juice. It is unusually stable in stomach acid, which is why it has been studied both by mouth and by injection.

TB-500 is a lab-made chain of 7 amino acids that copies one small region, amino acids 17 to 23, of thymosin beta-4. Thymosin beta-4 is a natural protein found in almost every cell and in wound fluid, and it plays a role in tissue repair. TB-500 is not the same molecule as full-length thymosin beta-4, which has 43 amino acids, and research on the full protein does not automatically apply to it. BPC-157 in Tampa and TB-500 in Tampa cover each one in depth.

How do BPC-157 and TB-500 work?

No one fully understands either one, and the possible actions come from lab and animal studies. BPC-157 appears to help new small blood vessels grow into injured tissue, and it interacts with the nitric oxide system, which helps control blood flow and protect the stomach and intestinal lining. FDA reviewers noted in 2026 that its molecular targets have not been identified.

TB-500 includes the part of thymosin beta-4 that binds actin, a protein cells use to change shape and move, which helps cells migrate into a wound. Thymosin beta-4 is also linked to new blood vessel growth and lower inflammation. It is not settled whether TB-500 itself does all of this: in a 2024 lab study, TB-500 did not speed the closure of scratched skin cells, while one of its breakdown products did.

What may each one help with?

BPC-157 may help with healing of tendons, ligaments and other injuries and may promote tissue repair, and oral BPC-157 may help the stomach and intestinal lining and the healing of ulcers. TB-500 may help with tissue repair, wound healing, inflammation and muscle recovery. These are possibilities from research, not promises, and neither replaces care for a diagnosed condition.

How strong is the research on each?

There is more animal research on BPC-157, and little human research on either. A 2025 systematic review found 36 BPC-157 studies relevant to sports medicine, 35 of them in animals, where it improved function, structure and strength after muscle, tendon, ligament and bone injuries. A 2026 review found only three small human studies of BPC-157, with 30 people in total and no comparison group, and rated the evidence as very low certainty.

For TB-500, FDA reviewers found no published human studies by any route in 2026, and no human safety data. Most of its support comes from animal research on full-length thymosin beta-4, plus a few animal studies of the fragment itself. A 2026 orthopaedic review stressed that results for the full protein cannot be applied to TB-500.

TB-500 vs BPC-157: which is better?

Neither has been shown to be better, because no study has compared them in people. In a 2026 rat study of repaired Achilles tendons, TB-500 injections were linked to stronger tendons and better tissue structure at four weeks, and adding BPC-157 gave no extra benefit. One rat study cannot tell you which suits you. Your provider weighs your injury or goal, your health history and the form you prefer, and decides with you whether one, both or neither makes sense.

Which forms do BPC-157 and TB-500 come in?

At Padgett, BPC-157 comes as an oral capsule or an injection, and TB-500 comes as an injection only, so if you would rather not inject, BPC-157 is the one of the two you can take by mouth. Both match the forms the October 2026 HHS interim policy lists: BPC-157 by injection under the skin or into a muscle, by mouth or on the skin, and TB-500 by injection under the skin or into a muscle.

BPC-157 capsules are $12 per capsule, and a BPC-157 injection vial, a month's supply, is $275. A TB-500 vial is $300, used generally twice a week. On a new patient's first order with a card on file, those are $10.80 per capsule, $247.50 and $270. Every product is listed in peptide therapy cost in Tampa.

Can you take BPC-157 and TB-500 together?

They can be prescribed together, but only as two separate products, never as one blended product. The HHS interim policy covers one peptide per product, so blends are outside it, and each peptide is compounded on its own. No one has studied the combination in people. In the 2026 rat tendon study, combining them gave no extra benefit, and an FDA report described darkening of the skin and gums in a person using an online "research use only" blend of the two. If both are prescribed, each has its own price and its own instructions.

Who should not take BPC-157 or TB-500?

The two share most of their cautions. Neither is for anyone who is pregnant, trying to become pregnant or breastfeeding, or for anyone under 18. Neither is advised with active cancer, a history of cancer, or an undiagnosed lump or growth, because both are linked to new blood vessel growth, and thymosin beta-4 has been tied to tumor cell migration in lab and mouse studies. Both are prohibited at all times for drug-tested athletes under World Anti-Doping Agency rules.

BPC-157 adds one more caution: it changed blood clotting times in animal studies, so tell your provider if you have a bleeding or clotting disorder or take a blood thinner. Neither peptide is FDA-approved. In July 2026, an FDA advisory committee voted 8 to 6, with 1 abstention, to recommend adding each to the list of substances pharmacies may compound from, after FDA staff had recommended against it. The vote is advisory. Compounded peptides have not been approved by the FDA.

How do you get BPC-157 or TB-500 in Tampa?

Start with a free consultation with a licensed provider, in person at our clinic at 6904 W. Linebaugh Ave or by telehealth from anywhere in Florida. If one or both fit, each is compounded for you by a licensed U.S. compounding pharmacy. That is not the same as "research grade" BPC-157 or TB-500 sold online, which is labeled not for human use and is not made or checked to pharmacy standards for people (why that matters). Book a free consultation about BPC-157 and TB-500, or see peptide therapy in Tampa for all six peptides.

This article is educational and is not medical advice. Talk with a licensed provider about your own health, medications and treatment options.